Press releases

(February 16, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the United Kingdom's National...

(February 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference, which is...

and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today provided financial guidance for 2005 and announced financial goals for 2006 and 2007 at a meeting with...

(January 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed the initial launch of its TAXUS® Liberté™ paclitaxel-eluting coronary stent system. On...

(January 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) will simultaneously webcast the analyst meeting it is hosting on Tuesday, February 1. The meeting is scheduled to begin at 9:00 a.m....

(January 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Piper Jaffray Health Care Conference, which is being held January 25-27 in New York City....

(January 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the implantation of its millionth TAXUS® Express2™ paclitaxel-eluting coronary stent system, marking a major...

(January 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has launched its TAXUS™ Liberté™ paclitaxel-eluting coronary stent system in 18 countries. The TAXUS...

and San Francisco, CA (January 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced preliminary, unaudited sales results for the fourth quarter and for the year ended December...

(January 6, 2005)-- Boston Scientific Corporation (NYSE: BSX) announced today that the U.S. District Court in Delaware has granted summary judgment of non-infringement in favor of Boston...